Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Oral Dis ; 18(3): 260-4, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-22059932

RESUMO

The aim of this study is to evaluate the oral colonization by Candida albicans in experimental murine immunosuppressed DBA/2 and treatment with probiotic bacteria. To achieve these objectives, 152 DBA/2-immunosuppressed mice were orally inoculated with a suspension of C. albicans containing 10(8) viable yeast cells, the animals were treated with nystatin or with the probiotics (Lactobacillus acidophilus and Lactobacillus rhamnosus). Evaluations were performed by Candida count from oral mucosa swabbing. The oral mucosa colonization by C. albicans started at day 1 after inoculation, remained maximal from day 3 until day 7, and then decreased significantly. Probiotics reduced the C. albicans colonization significantly on the oral mucosa in comparison with the untreated animal group. In the group treated with L. rhamnosus, the reduction in yeast colonization was significantly higher compared with that of the group receiving nystatin. Immunosuppressed animal model DBA/2 is a relevant model for experimental Candida oral colonization, and the treatment with probiotics in this model may be an effective alternative to prevent it.


Assuntos
Candidíase Bucal/terapia , Terapia de Imunossupressão , Probióticos/uso terapêutico , Animais , Antifúngicos/uso terapêutico , Candida/isolamento & purificação , Candidíase Bucal/tratamento farmacológico , Contagem de Colônia Microbiana , Ciclofosfamida/administração & dosagem , Modelos Animais de Doenças , Imunossupressores/administração & dosagem , Lactobacillus acidophilus , Lacticaseibacillus rhamnosus , Masculino , Camundongos , Camundongos Endogâmicos DBA , Mucosa Bucal/microbiologia , Nistatina/uso terapêutico , Palato/microbiologia , Distribuição Aleatória , Língua/microbiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA